1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Cao(Shandong Provincial Hospital), Ming Wei(Jinyintan Hospital), Yanqing Fan(Jinyintan Hospital), Jiaan Xia, Min Liu(China-Japan Friendship Hospital), Qiongya Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiuyang Xu(Tsinghua University), Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Ping Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xianguang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qun Yao(Chinese Academy of Medical Sciences & Peking Union Medical College), Dan Liu(Florida State University), Li Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanping Li(Zhejiang Chinese Medical University), Jianwei Wang(Zhejiang Cancer Hospital), Xia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Caihong Li(Jinyintan Hospital), Xiao Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueyang Zhang(Tsinghua University), Yeming Wang(China-Japan Friendship Hospital), Lili Ren(Huaibei Normal University), Yali Qu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ting Yu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1,129
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k